Clearside Biomedical, Inc.
DelistedCIK 1539029fmd_1HXMB3BX88MXMJNVB86KXEM370Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2025, 44 periods
Latest annual · FY2024
Millions- Total revenues
- 2
- Gross profit
- 2
- Operating income
- (29)
- Net income
- (34)
- Free cash flow
- (26)
Latest quarter · Q3 FY2025
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (7)
- Net income
- (6)
- Free cash flow
- (5)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- -61.7%
- Revenue, 5 yearsFY2019 to FY2024
- -5.2%
- Net income, 5 yearsFY2019 to FY2024
- n/m
Clearside Biomedical, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.7 million | $8.2 million | -79.8% | 10-K 2025-03-27 · proof |
| Gross profit | $1.5 million | $7.9 million | -80.8% | 10-K 2025-03-27 · proof |
| Operating income | -$28.9 million | -$24.8 million | 10-K 2025-03-27 · proof | |
| Net income | -$34.4 million | -$32.5 million | 10-K 2025-03-27 · proof | |
| Cash from operating activities | -$24.7 million | -$18.1 million | 10-K 2025-03-27 · proof | |
| Free cash flow | -$25.7 million | -$19.9 million | 10-K 2025-03-27 · proof | |
| Total assets | $25.1 million | $34 million | -26.1% | 10-K 2025-03-27 · proof |
| Total liabilities | $64 million | $49.9 million | +28.1% | 10-K 2025-03-27 · proof |
| Cash and cash equivalents | $20 million | $28.9 million | -30.8% | 10-K 2025-03-27 · proof |
- What was Clearside Biomedical, Inc.'s revenue in fiscal 2024?
- Clearside Biomedical, Inc. reported revenue of $1.7 million for fiscal 2024 (the year ended Dec 31, 2024), against $8.2 million the year before (-79.8%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was Clearside Biomedical, Inc.'s gross profit in fiscal 2024?
- Clearside Biomedical, Inc. reported gross profit of $1.5 million for fiscal 2024 (the year ended Dec 31, 2024), against $7.9 million the year before (-80.8%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was Clearside Biomedical, Inc.'s operating income in fiscal 2024?
- Clearside Biomedical, Inc. reported operating income of -$28.9 million for fiscal 2024 (the year ended Dec 31, 2024), against -$24.8 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was Clearside Biomedical, Inc.'s net income in fiscal 2024?
- Clearside Biomedical, Inc. reported net income of -$34.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$32.5 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was Clearside Biomedical, Inc.'s cash from operating activities in fiscal 2024?
- Clearside Biomedical, Inc. reported cash from operating activities of -$24.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$18.1 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What was Clearside Biomedical, Inc.'s free cash flow in fiscal 2024?
- Clearside Biomedical, Inc. reported free cash flow of -$25.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$19.9 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What are Clearside Biomedical, Inc.'s total assets?
- As of Dec 31, 2024, Clearside Biomedical, Inc. reported total assets of $25.1 million, against $34 million a year earlier (-26.1%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What are Clearside Biomedical, Inc.'s total liabilities?
- As of Dec 31, 2024, Clearside Biomedical, Inc. reported total liabilities of $64 million, against $49.9 million a year earlier (+28.1%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
- What are Clearside Biomedical, Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, Clearside Biomedical, Inc. reported cash and cash equivalents of $20 million, against $28.9 million a year earlier (-30.8%). Source: the 10-K filed with the SEC on Mar 27, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1539029&period_type=annual&limit=5"Information only, not investment advice.